US Patent Issued to Multivir on Oct. 28 for "Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer" (Texas Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,561, issued on Oct. 28, was assigned to Multivir Inc. (Houston).

"Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer" was invented by Robert E. Sobol (Houston), Kerstin B. Menander (Houston), Dora Wiederhold (Houston) and Sunil Chada (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one CD 122/CD 132 agonist, at least one immune checkpoint inhibitor and a viral composition comprising one or more viruses engineered to overe...